Skip to main content
Top
Published in: International Urology and Nephrology 1/2012

01-02-2012 | Nephrology – Original Paper

The contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy after primary percutaneous coronary intervention

Authors: Yong Liu, Ning Tan, Ying-Ling Zhou, Peng-Cheng He, Jian-Fang Luo, Ji-Yan Chen

Published in: International Urology and Nephrology | Issue 1/2012

Login to get access

Abstract

Background

Contrast-induced nephropathy (CIN) is a serious complication in percutaneous coronary intervention (PCI) patients, which may be related to the contrast dose used during cardiac catheterization.

Methods

We prospectively investigated 277 consecutive consenting patients with acute ST-segment elevation myocardial infarction (STEMI) who were given primary PCI, and we calculated their ratio of volume of contrast media to estimated glomerular filtration rate (V/eGFR). Receiver–operator characteristic methods were used to identify the optimal sensitivity for the observed range of V/eGFR for CIN (i.e., within 48–72 h). The predictive value of V/eGFR for the risk of CIN was assessed using multivariable logistic regression.

Results

Twenty-five (9%) patients developed CIN. The baseline mean and median V/eGFR values were significantly greater among patients with CIN (mean 3.22 ± 1.53, median 2.97, and interquartile range 1.90–4.17) than among those without CIN (mean 1.80 ± 1.00, median 1.52, and interquartile range 1.12–2.21, P < 0.001). The receiver–operator characteristic curve analysis indicated that a V/eGFR ratio of 2.39 was a fair discriminator for CIN (C statistic 0.81). After adjusting for other known predictors of CIN, a V/eGFR ratio ≥ 2.39 remained significantly associated with CIN (odds ratio 4.24, 95% confidence interval 1.23–14.66, P < 0.05).

Conclusion

A V/eGFR ratio ≥ 2.39 was a significant and independent predictor of CIN after primary PCI in patients with STEMI.
Literature
1.
go back to reference Mehran R, Nikolsky E (2006) Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl 100:11–15CrossRef Mehran R, Nikolsky E (2006) Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl 100:11–15CrossRef
2.
go back to reference Morcos SK (2005) Prevention of contrast media nephrotoxicity following angiographic procedures. J Vasc Interv Radiol 16:13–23PubMedCrossRef Morcos SK (2005) Prevention of contrast media nephrotoxicity following angiographic procedures. J Vasc Interv Radiol 16:13–23PubMedCrossRef
3.
go back to reference Mehran R, Aymong ED, Nikolsky E et al (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 44:1393–1399PubMed Mehran R, Aymong ED, Nikolsky E et al (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 44:1393–1399PubMed
4.
go back to reference Bartholomex BA, Harjai KJ, Dukkipati S et al (2004) Impact of nephropathy after percutaneous coronary intervention and a method of risk stratification. Am J Cardiol 93:1515–1519CrossRef Bartholomex BA, Harjai KJ, Dukkipati S et al (2004) Impact of nephropathy after percutaneous coronary intervention and a method of risk stratification. Am J Cardiol 93:1515–1519CrossRef
5.
go back to reference Cigarroa RG, Lange RA, Williams RH, Hillis LD (1989) Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86:649–652PubMedCrossRef Cigarroa RG, Lange RA, Williams RH, Hillis LD (1989) Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86:649–652PubMedCrossRef
6.
go back to reference Freeman RV, O’Donnell M, Share D et al (2002) Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 90:1068–1073PubMedCrossRef Freeman RV, O’Donnell M, Share D et al (2002) Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 90:1068–1073PubMedCrossRef
7.
go back to reference Giancarlo M (2009) Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 150:170–177 Giancarlo M (2009) Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 150:170–177
8.
go back to reference Madsen TE, Pearson RR, Muhlestein JB et al (2009) Risk of nephropathy is not increased by the administration of larger volume of contrast during coronary angiography. Crit Pathw Cardiol 8:167–171PubMed Madsen TE, Pearson RR, Muhlestein JB et al (2009) Risk of nephropathy is not increased by the administration of larger volume of contrast during coronary angiography. Crit Pathw Cardiol 8:167–171PubMed
10.
go back to reference Bourin M, Jolliet P, Ballereau F (1997) An overview of the clinical pharmacokinetics of X-ray contrast media. Clin Pharmacokinet 32:180–193PubMedCrossRef Bourin M, Jolliet P, Ballereau F (1997) An overview of the clinical pharmacokinetics of X-ray contrast media. Clin Pharmacokinet 32:180–193PubMedCrossRef
11.
go back to reference Warren K et al (2007) Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatine increase after percutaneous coronary intervention. J Am Coll Cardiol 50:584–590CrossRef Warren K et al (2007) Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatine increase after percutaneous coronary intervention. J Am Coll Cardiol 50:584–590CrossRef
12.
go back to reference Marenzi G, Lauri G, Assanelli E et al (2004) Contrast-induced nephropathy in patients undergoing primary angiography for acute myocardial infarction. J Am Coll Cardiol 44:1780–5178PubMedCrossRef Marenzi G, Lauri G, Assanelli E et al (2004) Contrast-induced nephropathy in patients undergoing primary angiography for acute myocardial infarction. J Am Coll Cardiol 44:1780–5178PubMedCrossRef
13.
go back to reference Levey AS, Greene T, Kusek J et al (2000) A simplified equation to predict GFR from serum creatinine. J Am Soc Nephrol 11:155A Levey AS, Greene T, Kusek J et al (2000) A simplified equation to predict GFR from serum creatinine. J Am Soc Nephrol 11:155A
14.
go back to reference Van de Werf F, Ardissino D, Betriu A et al (2003) Management of acute myocardial infarctionin patients presenting with ST-segment elevation. Eur Heart J 24:28–66PubMedCrossRef Van de Werf F, Ardissino D, Betriu A et al (2003) Management of acute myocardial infarctionin patients presenting with ST-segment elevation. Eur Heart J 24:28–66PubMedCrossRef
15.
go back to reference Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264PubMedCrossRef Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264PubMedCrossRef
16.
go back to reference Morris TW, Katzberg RW, Fischer HW (1978) A comparison of the hemodynamic responses to metrizamide and meglumine/sodium diatrizoate in canine renal angiography. Invest Radiol 13:74–78PubMedCrossRef Morris TW, Katzberg RW, Fischer HW (1978) A comparison of the hemodynamic responses to metrizamide and meglumine/sodium diatrizoate in canine renal angiography. Invest Radiol 13:74–78PubMedCrossRef
17.
go back to reference Liss P, Nygren A, Olsson U et al (1996) Effects of contrast media and mannitol on renal medullary blood flow and red cell aggregation in the rat kidney. Kidney Int 49:1268–1275PubMedCrossRef Liss P, Nygren A, Olsson U et al (1996) Effects of contrast media and mannitol on renal medullary blood flow and red cell aggregation in the rat kidney. Kidney Int 49:1268–1275PubMedCrossRef
18.
go back to reference Fujisaki K, Kubo M, Masuda K et al (2003) Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function. Clin Exp Nephrol 7:279–283PubMedCrossRef Fujisaki K, Kubo M, Masuda K et al (2003) Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function. Clin Exp Nephrol 7:279–283PubMedCrossRef
19.
go back to reference Humes HD, Hunt DA, White MD (1987) Direct toxic effect of the radiocontrast agent diatrizoate on renal proximal tubule cells. Am J Physiol 252:246–255 Humes HD, Hunt DA, White MD (1987) Direct toxic effect of the radiocontrast agent diatrizoate on renal proximal tubule cells. Am J Physiol 252:246–255
20.
go back to reference Mueller C, Buerkle G, Buettner HJ et al (2002) Prevention of contrast-associated nephropathy. Arch Intern Med 162:329–336PubMedCrossRef Mueller C, Buerkle G, Buettner HJ et al (2002) Prevention of contrast-associated nephropathy. Arch Intern Med 162:329–336PubMedCrossRef
21.
go back to reference Pakfetrat M, Nikoo MH, Malekmakan L et al (2009) A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial. Int Urol Nephrol 41(3):629–634PubMedCrossRef Pakfetrat M, Nikoo MH, Malekmakan L et al (2009) A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial. Int Urol Nephrol 41(3):629–634PubMedCrossRef
22.
go back to reference Kanbay M, Covic A, Coca SG et al (2009) Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials. Int Urol Nephrol 41(3):617–627PubMedCrossRef Kanbay M, Covic A, Coca SG et al (2009) Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials. Int Urol Nephrol 41(3):617–627PubMedCrossRef
23.
go back to reference Sherwin PF, Cambron R, Johnson JA et al (2005) Contrast dose-to-creatinine clearance ratio as a potential indicator of risk for radiocontrast-induced nephropathy: correlation of D/CrCL with area under the contrast concentration time curve using iodixanol. Invest Radiol 40:598–603PubMedCrossRef Sherwin PF, Cambron R, Johnson JA et al (2005) Contrast dose-to-creatinine clearance ratio as a potential indicator of risk for radiocontrast-induced nephropathy: correlation of D/CrCL with area under the contrast concentration time curve using iodixanol. Invest Radiol 40:598–603PubMedCrossRef
24.
go back to reference Altmann DB, Zwas D, Spatz A et al (1997) Use of the contrast volume to estimated creatinine clearance ratio to predict renal failure after angiography. J Intervent Cardiol 10:113–119CrossRef Altmann DB, Zwas D, Spatz A et al (1997) Use of the contrast volume to estimated creatinine clearance ratio to predict renal failure after angiography. J Intervent Cardiol 10:113–119CrossRef
25.
go back to reference Perrone RD, Madias NE, Levey AS (1992) Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 38:1933–1953PubMed Perrone RD, Madias NE, Levey AS (1992) Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 38:1933–1953PubMed
26.
go back to reference Goldberg A, Hammerman H, Petcherski S et al (2005) In-hospital and one year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J 150:330–337PubMedCrossRef Goldberg A, Hammerman H, Petcherski S et al (2005) In-hospital and one year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J 150:330–337PubMedCrossRef
27.
go back to reference Rosenstock JL, Gilles E, Geller AB et al (2010) Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease. Int Urol Nephrol 42(4):1049–1054PubMedCrossRef Rosenstock JL, Gilles E, Geller AB et al (2010) Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease. Int Urol Nephrol 42(4):1049–1054PubMedCrossRef
Metadata
Title
The contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy after primary percutaneous coronary intervention
Authors
Yong Liu
Ning Tan
Ying-Ling Zhou
Peng-Cheng He
Jian-Fang Luo
Ji-Yan Chen
Publication date
01-02-2012
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2012
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-011-9910-4

Other articles of this Issue 1/2012

International Urology and Nephrology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.